newsfilter
← Latest News
PR Newswire·

Heska Corporation Signs Exclusive Agreement to Introduce Nu.Q® Vet Cancer Screening Test, First-Ever Point of Care Cancer Screen

LOVELAND, Colo., March 29, 2022 /PRNewswire/ -- Heska Corporation (NASDAQ:HSKA) ("Heska"), a leading global provider of advanced veterinary diagnostics, has announced an exclusive global supply and licensing agreement with VolitionRx Limited (NYSE:VNRX)